These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33886668)

  • 1. A primary Chlamydia trachomatis genital infection of rhesus macaques identifies new immunodominant B-cell antigens.
    Randall A; Teng A; Liang X; Pal S; Tarantal AF; Fike J; Barry PA; de la Maza LM
    PLoS One; 2021; 16(4):e0250317. PubMed ID: 33886668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole genome identification of C. trachomatis immunodominant antigens after genital tract infections and effect of antibiotic treatment of pigtailed macaques.
    Patton DL; Teng A; Randall A; Liang X; Felgner PL; de la Maza LM
    J Proteomics; 2014 Aug; 108():99-109. PubMed ID: 24862987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Human-Specific Immunodominant
    Rahman KS; Darville T; Russell AN; O'Connell CM; Wiesenfeld HC; Hillier SL; Chowdhury EU; Juan YC; Kaltenboeck B
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30068558
    [No Abstract]   [Full Text] [Related]  

  • 4. Proteome array of antibody responses to Chlamydia trachomatis infection in nonhuman primates.
    Lu C; Sun Z; Chen H; Chen L; Zhu C; Chen C; Li C; Peng B; Zhong G
    Life Sci; 2020 May; 248():117444. PubMed ID: 32084433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to Variable Domain 4 Linear Epitopes of the
    Collar AL; Linville AC; Core SB; Wheeler CM; Geisler WM; Peabody DS; Chackerian B; Frietze KM
    mSphere; 2020 Sep; 5(5):. PubMed ID: 32968007
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of immunodominant antigens of Chlamydia trachomatis using proteome microarrays.
    Molina DM; Pal S; Kayala MA; Teng A; Kim PJ; Baldi P; Felgner PL; Liang X; de la Maza LM
    Vaccine; 2010 Apr; 28(17):3014-24. PubMed ID: 20044059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic profiling of a Chlamydia trachomatis gene-expression library.
    Follmann F; Olsen AW; Jensen KT; Hansen PR; Andersen P; Theisen M
    J Infect Dis; 2008 Mar; 197(6):897-905. PubMed ID: 18288899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of immunodominant antigens by probing a whole Chlamydia trachomatis open reading frame proteome microarray using sera from immunized mice.
    Cruz-Fisher MI; Cheng C; Sun G; Pal S; Teng A; Molina DM; Kayala MA; Vigil A; Baldi P; Felgner PL; Liang X; de la Maza LM
    Infect Immun; 2011 Jan; 79(1):246-57. PubMed ID: 20956570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of protective immune responses promoted by human antigen targets in a urogenital Chlamydia trachomatis mouse model.
    Olsen AW; Andersen P; Follmann F
    Vaccine; 2014 Feb; 32(6):685-92. PubMed ID: 24365515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies from women urogenitally infected with C. trachomatis predominantly recognized the plasmid protein pgp3 in a conformation-dependent manner.
    Li Z; Zhong Y; Lei L; Wu Y; Wang S; Zhong G
    BMC Microbiol; 2008 Jun; 8():90. PubMed ID: 18541036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of primate model system to identify Chlamydia trachomatis protein antigens recognized uniquely in the context of infection.
    Bannantine JP; Rockey DD
    Microbiology (Reading); 1999 Aug; 145 ( Pt 8)():2077-2085. PubMed ID: 10463174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prior genital tract infection with a murine or human biovar of Chlamydia trachomatis protects mice against heterotypic challenge infection.
    Ramsey KH; Cotter TW; Salyer RD; Miranpuri GS; Yanez MA; Poulsen CE; DeWolfe JL; Byrne GI
    Infect Immun; 1999 Jun; 67(6):3019-25. PubMed ID: 10338514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic identification of immunodominant chlamydial antigens in a mouse model.
    Teng A; Cruz-Fisher MI; Cheng C; Pal S; Sun G; Ralli-Jain P; Molina DM; Felgner PL; Liang X; de la Maza LM
    J Proteomics; 2012 Dec; 77():176-86. PubMed ID: 22959960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A secondary structure motif predictive of protein localization to the chlamydial inclusion membrane.
    Bannantine JP; Griffiths RS; Viratyosin W; Brown WJ; Rockey DD
    Cell Microbiol; 2000 Feb; 2(1):35-47. PubMed ID: 11207561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine.
    Ifere GO; He Q; Igietseme JU; Ananaba GA; Lyn D; Lubitz W; Kellar KL; Black CM; Eko FO
    J Microbiol Immunol Infect; 2007 Jun; 40(3):188-200. PubMed ID: 17639158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice.
    Wang J; Chen L; Chen F; Zhang X; Zhang Y; Baseman J; Perdue S; Yeh IT; Shain R; Holland M; Bailey R; Mabey D; Yu P; Zhong G
    Vaccine; 2009 May; 27(22):2967-80. PubMed ID: 19428908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling of human antibody responses to Chlamydia trachomatis urogenital tract infection using microplates arrayed with 156 chlamydial fusion proteins.
    Sharma J; Zhong Y; Dong F; Piper JM; Wang G; Zhong G
    Infect Immun; 2006 Mar; 74(3):1490-9. PubMed ID: 16495519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approach to discover T- and B-cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines.
    Finco O; Frigimelica E; Buricchi F; Petracca R; Galli G; Faenzi E; Meoni E; Bonci A; Agnusdei M; Nardelli F; Bartolini E; Scarselli M; Caproni E; Laera D; Zedda L; Skibinski D; Giovinazzi S; Bastone R; Ianni E; Cevenini R; Grandi G; Grifantini R
    Proc Natl Acad Sci U S A; 2011 Jun; 108(24):9969-74. PubMed ID: 21628568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of protective immunity against Chlamydia muridarum intravaginal infection with the chlamydial immunodominant antigen macrophage infectivity potentiator.
    Lu C; Peng B; Li Z; Lei L; Li Z; Chen L; He Q; Zhong G; Wu Y
    Microbes Infect; 2013 Apr; 15(4):329-38. PubMed ID: 23416214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of multiple genital tract infections with Chlamydia trachomatis in different strains of female mice.
    Lyons JM; Morré SA; Airo-Brown LP; Peña AS; Ito JI
    J Microbiol Immunol Infect; 2005 Dec; 38(6):383-93. PubMed ID: 16341338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.